Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages 139-145 , May 2010

Association between polymorphisms in human tumor necrosis factor-alpha (−308) and -beta (252) genes and development of gestational diabetes mellitus

  • Shabnam Montazeri

      Affiliations

    • Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, International Medical University, 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia
    • Department of Pathology, Faculty of Medicine and Health, International Medical University, 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia
    • Corresponding Author InformationCorresponding author at: Faculty of Medicine and Health, International Medical University, 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia. Tel.: +60 3 86567228; fax: +60 3 86567229.
    • ,
  • Sivalingam Nalliah

      Affiliations

    • Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, International Medical University, 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia
    • ,
  • Ammu Kutty Radhakrishnan

      Affiliations

    • Department of Pathology, Faculty of Medicine and Health, International Medical University, 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia

Received 19 August 2009 ,Revised 21 January 2010 ,Accepted 28 January 2010.

References 

  1. Diagnosis and Classification of Diabetes Mellitus. Report of a WHO Consultation. Geneva: World Health Organization, Department of Non-communicable Disease Surveillance; 1999;
  2. Metzger BE. Summary and recommendation of the third International work shop: conference on gestational diabetes mellitus. Diabetes. 1991;40:197–202
  3. Luesley DM, Baker PN. Obstetrics and Gynecology, Evidence Based Text for MRCOG. London: Arnold Publication; 2004;pp. 172–174
  4. Winkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajos P, et al. Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res. Clin. Pract. 2002;56(2):93–99
  5. Greenberg AS, McDaniel ML. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipose-derived cytokines in the pathogenesis of type 2 diabetes. Eur. J. Clin. Invest. 2000;32:24–34
  6. Warle MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, zondervan PE, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profile?. Liver Transplant. 2003;9(2):170–181
  7. Kubaszek A, Pihlajamäki J, Komarovski V, Lindi V, Lindström J, Eriksson J, et al. Promoter polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. Diabetes. 2003;52:1872–1876
  8. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 1998;83:2907–2910
  9. Kroeger KM, Carville KS, Abraham LJ. The −308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 1997;34:391–399
  10. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 1997;94:3195–3199
  11. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease. Scand. J. Immunol. 1996;43:456–463
  12. Fernandez-Real J, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, et al. The TNFalpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes. 1997;46:1468–1472
  13. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes. Res. 2002;10:401–407
  14. Koch M, Rett K, Volk A, Maerker E, Haist K, Weisser M, et al. The tumor necrosis factor alpha −238 G→A and −308 G→A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of type 2 diabetic patients. Diabetologia. 2000;43:181–184
  15. Rusmusse SK, Urhammer SA, Jensen JN. The polymorphism of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J. Clin. Endocrinol. Metab. 2000;85:1731–1734
  16. Um JY, Hyung-Mn Kim HM. Frequencies of the tumor necrosis factor polymorphisms in the Korean population. Hereditas. 2003;139:184–188
  17. Casano-Sancho P, Lopez-Bermejot A, Frenandez-Real JM, Monros E, Valls C, Rodriguez-Gonzalez F, et al. The tumour necrosis factor (TNF)-a −308GA promoter polymorohism is related to prenatal growth and postnatal insulin resistance. Clin. Endocrinol. 2006;64:129–135
  18. Stanulla M, Schrauder A, Welt K, Schrape M. Tumour necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell acute lymphoblastic leukaemia. BMC Blood Disord. 2001;1(2):1–6
  19. Porter AG. Human tumor necrosis factor-alpha and -beta: differences in their structure, expression and biological properties. FEMS Microbiol. Immunol. 1990;2(4):193–199
  20. Takashige N, Naruse TK, Matsumori A, Hara M, Nagai S, Moromoto S, et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens. 1999;54:191–193
  21. Fei BY, Deng CS, Xia B, You-Qing Z, Bart AC, Salvador PA. Polymorphisms at the TNF locus in Chinese Han population. Hum. Immunol. 2002;63:71–75
  22. Lee SC, Pu YB, Thomas GN, Leee ZSK, Tomlinson B, Cockram S, et al. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism. 2000;49:1021–1024
  23. Hoffstedt J, Eriksson P, Helllstrom L, Rossner S, Ryden M, Arner P. Excessive fat accumulationis associated with the TNF α −308 G/A promoter polymorphism in women but not in men. Diabetologia. 2000;43:117–120
  24. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evince A, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur. J. Clin. Invest. 1998;28:59–66
  25. Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, Distler A, et al. Tumor necrosis factor-alpha −308 G/A polymorphism in obese Caucasians. Int. J. Obs. Relat. Metab. Disord. 2001;25:581–585
  26. Howell WM, Turner SJ, Collins A, Bateman AC, Theaker JM. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur. J. Immunogenet. 2002;29:17–23
  27. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. Association of the TNF a −308 G/A promoter polymorphism with insulin resistance in obesity. Obes. Res. 2002;10:401–407
  28. Shiau MY, Wu CY, Huang CN, Hu SW, Lin SJ, Chang YH. TNF α polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens. 2003;61(5):393–399
  29. Walston J, Seibert M, Yen CJ, Cheskin LJ, Andersen RE. Tumor necrosis factor-alpha −238 and −308 polymorphisms do not associated with traits related to obesity and insulin resistance. Diabetes. 1999;48:2096–2098
  30. Kirwan J, Mouzon S, Lepercq J, Challier J, Huston-Presley L, Friedman J, et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207–2213
  31. Vince GS, Johnson PM. Is there a TH2 bias in human pregnancy?. J. Reprod. Immunol. 1996;32:101–104
  32. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-alpha. J. Clin. Invest. 1993;94:1543–1549
  33. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1994;259:87–91
  34. Tsiotra PC, Tsigos C, Raptis SA. TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int. J. Obes. Relat. Metab. Disord. 2001;25:1018–1026
  35. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995;95:2409–2415
  36. Stephens JM, Lee J, Pilch PF. Tumor necrosis factor alpha induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT-4 expression without a loss of insulin-receptor-mediated transduction. J. Biol. Chem. 1997;272:971–976
  37. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes. 1996;45:881–885
  38. Bluher M, Kratzsch J, Paschke R. Plasma levels of tumor necrosis factor-α, angiotensin II, growth hormone and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diabetes Care. 2001;24:328–334
  39. Mclachlan KA, O’Neal D, Jenkins A, Alford FA. Do Adiponectin, TNF-α, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab. Res. Rev. 2006;22:131–138

PII: S0168-8227(10)00051-3

doi: 10.1016/j.diabres.2010.01.028

Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages 139-145 , May 2010

Article Tools

* Image Usage & Resolution